LONDON, Sept. 13, 2024 ~ Cambridge Healthcare Research (CHR) has announced the appointment of Jeanne Penn as the new Vice President of US Commercial for their strategic competitive intelligence division, Solici. This move comes as part of the company's efforts to further expand and establish its presence in the US market.

Brendan Walkden, Head of Solici, expressed his excitement about having Penn join their team. He praised her extensive experience and leadership skills in the industry and emphasized the importance of partnering with someone of her caliber during this crucial time of growth for the business. Walkden also looks forward to working with Penn and utilizing her strategic insights and strong relationships to drive Solici's continued growth.

Penn brings decades of experience in providing market insights to the biopharma industry. She has previously worked for Genzyme (now Sanofi) and EMD Serono (known as Merck KGaA outside the US), where she led competitive intelligence, market research, and forecasting for multiple brands. Her expertise covers a wide range of therapy areas, but she has a special passion for rare diseases.

More on Boston Chron

• Purple Union C-Murder Supporting Angola Prisoners in Their Fight for Basic Human Rights Through Labor Strike
• Boston: Age Strong Blog: 2024 Age Strong Senior Civic Academy Session 1
• Boston: Mayor Wu Announces New Details on Applying for New Liquor Licenses
• Boston: Age Strong Blog: Feliz aniversario, Nuevo Dia!
• OpsVeda Is Now Available Through AWS Marketplace

In addition to her industry experience, Penn has also worked on the consulting side with companies such as DRG (now Clarivate), Lifescience Dynamics, and Prescient Healthcare Group. She has led teams in delivering high-quality analysis to various US-based clients and is known for her skills as a facilitator and business leader.

Penn's contributions to empowering women in the workplace have been recognized by the Healthcare Businesswomen's Association, who named her a Luminary in 2022. She is married with two adult children.

Stephen Galt, Chief Commercial Officer of CHR, expressed his delight at having Penn join their team as they strengthen their physical presence in the US market. He believes that her leadership skills and industry expertise will play a crucial role in driving CHR's growth forward. Galt also highlighted Penn's experience in forming high-performing teams and her strategic leadership in commercial teams, which will be valuable assets in their partnership moving forward.

With the addition of Jeanne Penn to their team, CHR and Solici are poised for continued success and growth in the US market. Penn's extensive experience and leadership skills make her a valuable asset to the company, and her appointment is a testament to CHR's commitment to providing top-notch services to their clients.

---

Show All News | Report Violation